-+ 0.00%
-+ 0.00%
-+ 0.00%

VTV THERAPEUTICS APPOINTS MICHAEL TUNG, M.D., MBA, TO CHIEF FINANCIAL OFFICER AS COMPANY REINITIATES PHASE 3 TRIAL OF ORAL T1D ADJUNCTIVE THERAPY TO INSULIN

Reuters·05/19/2025 13:00:00

Please log in to view news